ArticleScientific reports2025
Different approaches for estimating the shrinkage factor in ridge regression BLUP for genomic selection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrating Epistatic Interactions into Genomic Prediction of Growth and Fillet Fat Content in Common Carp.International journal of molecular sciences · 2026Article
- From linear models to deep learning: statistical advances in genomic selection for animal breeding.Journal of animal science and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The shrinkage factor (λ) plays a critical role in shrinkage-based methods such as Ridge Regression Best Linear Unbiased Prediction (RRBLUP) for genomic selection. In these methods, λ controls the strength of penalization applied to marker effect estimates, thereby regulating model complexity and improving prediction accuracy (PA). This study evaluated eight approaches for estimating λ in RRBLUP, alongside the widely used BayesC (BC) method, across diverse genetic architectures. Direct approaches included cross-validation based on mean squared error (MSE-RRBLUP) and Pearson correlation coefficient (PCC-RRBLUP), as well as information criterion-based methods (AIC-RRBLUP, BIC-RRBLUP, DIC-RRBLUP). Indirect approaches, which infer λ from marker effect variances, included the total marker number (NM-RRBLUP), the sum of allelic frequencies (AF-RRBLUP), and BC (RRBLUP-BC). The simulated genome comprised six chromosomes, 1 Morgan each, with 100 quantitative trait loci (QTLs) randomly positioned on each chromosome. Four scenarios were considered: Scenario 1: 3000 markers, h² = 0.2; Scenario 2: 3000 markers, h² = 0.6; Scenario 3: 9000 markers, h² = 0.2; Scenario 4: 9000 markers, h² = 0.6. The PA, measured as the PCC between true (simulated) and genomic estimated breeding values, indicated that indirect approaches generally outperformed direct ones, except for PCC-RRBLUP, which performed comparably to AF-RRBLUP. In contrast, Information criterion-based direct methods exhibited the lowest PA. Estimated λ values decreased with increasing heritability and decreasing predictor number, regardless of approach. Large effect sizes (Cohen's d) confirmed the practical significance of differences between the best and worst methods. The maximum distance in PA were observed between BC and DIC-RRBLUP (d = 1.51) and BC and AIC/BIC-RRBLUP (d = 1.37) in Scenario 4, both statistically significant (P < 0.05). Among penalized parameter estimation methods, the largest differences occurred between PCC-RRBLUP and DIC-RRBLUP (d = 1.36) and between AF-RRBLUP and DIC-RRBLUP (d = 1.34) in Scenario 4, indicating very strong practical differences. In conclusion, the AF-RRBLUP approach combines high PA with low computational burden, making it a recommended option among the evaluated methods for genomic selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.